Probi

Miss on Q3 sales (-12%) and EBITDA (-10%) vs ABGSCe China faced headwinds due to macroeconomic factors EBITDA revised down by 2-3% for '24e-'26e Encouraging B2C sales efforts in the Nordics Probi reported a soft Q3'24 with sales amounting to SEK 143....

Probi

Webcast10/22/2024, 8:00 AM

Probi, Audiocast with teleconference, Q3'24

Probi

Regulatory press release10/22/2024, 6:00 AM

Probi: Q3 2024: Tangible improvement in operations

Probi

Press release10/17/2024, 6:50 AM

Presentation of Probi's Q3 Report 2024

Probi

Press release10/16/2024, 11:30 AM

Probi partners with Global BHP BrainTrust and the FINGERS Brain Health Institute to counteract dementia

Probi

Press release10/10/2024, 7:00 AM

Nordic launch of Probi Sense - a unique dietary supplement for the mental capacity

Probi

Press release9/24/2024, 11:00 AM

New study strengthens Probi[ ][®]s L. plantarum HEAL9[®] strain in cognitive function

Probi

Third party research7/17/2024, 6:29 AM

Probi: FY'24e marks a transition to a promising future - ABG

- Beat on Q2 sales (+3%) and EBITDA (+24%) vs ABGSCe - EBITDA up 2% for '24e and 1% for '25e - Our comprehensive analysis indicates a promising long-term outlook Americas and EMEA progressed well in Q2 Probi reported a strong Q2'24 driven by growth in...

Probi

Probi

Join Inderes community

Inderes account

Join Inderes community

Inderes account